The Partnership to Improve Patient Care (PIPC), the American Association of People with Disabilities (AAPD), and over 80 other patient advocacy organizations have sent a formal comment letter urging CMS not to move forward with their proposed Part B Drug Payment Model. Instead, we hope to continue working with the agency and other stakeholders to ensure that, as it seeks to advance value-based health care, it is supporting care valued by patients and people with disabilities.
|
The Partnership to Improve Patient Care (PIPC)—whose members include organizations representing patients, people with disabilities and other stakeholders—today released a public opinion poll regarding healthcare delivery and access in America. The survey, which builds on prior surveys conducted by PIPC in 2013 and 2015, shows that of nearly 2,000 registered voters polled by Morning Consult, 8 in 10 say that doctors and patients should be able to decide the best course of treatment without government interference and that Medicare reforms should move toward patient-centered health care by giving physicians and patients the support they need to choose the best care for them
Private payers are already relying on one-size-fits-all assessments of value, often making it difficult for patients to access the care they want and need. Therefore, PIPC and its partners support the use of the National Health Council’s (NHC) Patient-Centered Value Model Rubric by developers of value assessments to mitigate the existing shortcomings of value assessments and tools. The NHC’s rubric already provides a guide to evaluate the patient-centeredness of value models and to gude value model developers on the meaningful incorporation of patient engagement throughout their processes
The Partnership to Improve Patient Care (PIPC) today released a public opinion poll regarding healthcare in America, indicating that Americans are interested in actively participating in treatment decision making, and want the government to have a limited say in what treatments they can access. The survey, which polled 1,500 registered voters, updates a survey originally conducted in 2013.
This week, Chairman Coelho sent a letter to the Medicare Payment Advisory Commission (MedPAC) in response to a recent session. In September's public meeting, the Commission discussed developing payment policy based on the use of clinical evidence, with specific focus on reinstating the least costly alternative (LCA) policy to Medicare Part B drugs and biologicals.
|
Topics
All
Archives
August 2022
|